Mumbai 400051, India
+91-90045 60540
info@omnisciencecapital.com

Month: September 2024

Science of Alpha from Safety

The Statesman: Indian EV Industry to become major power consumer amid robust growth: Report

With nearly four million electric vehicles (EVs) sold in India cumulatively by March this year, the market is in the midst of an explosive growth phase and will become a major power consumer. With an anticipated total power consumption of approximately 100 TWh by 2030, EVs have the potential to rank among the nation’s single…
Read more

Deccan Chronicle: India’s power consumption to rise to 3k TWh by 2030

“Electric Vehicles will dominate Indian roads by 2030 as the government targets 30% EV penetration on Indian roads by 2030. There are numerous government programs and subsidies, such FAME and PLI in place to encourage the use of EVs in India. “With an anticipated total power consumption of approximately 100 TWh by 2030, EVs have…
Read more

CNBC TV18: Sensex, Nifty eke out gains after profit booking seen from record levels

“The Fed’s rate cuts are likely to stimulate growth, with U.S. equities and emerging markets expected to gain in the long term, despite near-term volatility. For global investors, especially in emerging markets like India, cheaper financing could boost investment flows, particularly from Foreign Institutional Investors (FIIs).” – Dr. Vikas Gupta, CEO & Chief Investment Strategist…
Read more

Moneycontrol: Daily Voice: Time to book profits in pharma, Zomato looks overvalued, says portfolio manager

There is excitement in the pharma space, but with the Nifty Pharma index’s price-to-earnings (PE) valuation multiple at 38, the sector is fully priced for its growth outlook. Based on our scientific investing framework, we recommend taking some profits rather than increasing exposure.”  -Ashwini Shami (EVP and Portfolio Manager – OmniScience Capital) with Moneycontrol  …
Read more

Economic Times: Defence stocks rally as government approves Rs 1.4 lakh crore worth acquisition

The investment universe needs to be broadened to non-conventional proxy defence and other forms of more subtle defence so that undervalued companies can be found.” – Vikas Gupta CEO, OmniScience Capital Read More

Moneycontrol: Daily Voice: Few pure-play defence stocks still investible from valuation perspective, says OmniScience Capital’s Vikas Gupta

The fundamentals of defence stocks remain extremely strong in terms of revenue, profits, growth visibility, and order books. A few pure play defence stocks are still investible from a valuation perspective, but many appear overvalued. – Dr Vikas Gupta Read More